--- title: "Assessing Aviva (LSE:AV.) Valuation As DCF And P/E Send Mixed Signals" type: "News" locale: "en" url: "https://longbridge.com/en/news/279025868.md" description: "Aviva (LSE:AV.) is currently priced at £6.25, reflecting an 8.52% decline year-to-date, despite a 1-year total shareholder return of 23.05%. Analysts suggest a fair value of £6.83, indicating it may be undervalued. The DCF model estimates a future cash flow value of £12.46, while the P/E ratio of 24.8x is higher than the European insurance average of 12.6x, suggesting limited growth margin. Investors are advised to consider both the potential upside and risks, particularly regarding the integration of Direct Line and pricing pressures in personal lines." datetime: "2026-03-13T10:20:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279025868.md) - [en](https://longbridge.com/en/news/279025868.md) - [zh-HK](https://longbridge.com/zh-HK/news/279025868.md) --- # Assessing Aviva (LSE:AV.) Valuation As DCF And P/E Send Mixed Signals ## Why Aviva might be on your radar now Aviva (LSE:AV.) has been drawing attention recently as investors reassess insurers offering both protection and retirement products. Its current share price is around £6.25 and it has an annual revenue base of £28.68b. See our latest analysis for Aviva. At around £6.25, Aviva’s recent share price performance has been soft, with a year-to-date share price return showing an 8.52% decline. However, the 1-year total shareholder return of 23.05% and 5-year total shareholder return of 120.21% point to a much stronger longer-term picture that investors are weighing against current sentiment on insurers. If you are looking beyond large insurers for your next idea, this could be a good moment to scan our screener of 5 top founder-led companies and see what else stands out. With an intrinsic discount of around 50% and a value score of 2, Aviva’s current £6.25 share price raises a crucial question for you: is there genuine upside here, or has the market already factored in its future growth? ## Most Popular Narrative: 8.5% Undervalued With Aviva last closing at £6.25 against a narrative fair value of £6.83, the most widely followed view sees some headroom priced into its long term cash flows. > _Accelerating the shift to 'capital-light' businesses (now over 66% of earnings and targeting 70%+ after the Direct Line integration) is associated with improved group profit margins, lower capital requirements, and better return on equity, supporting a positive outlook for net earnings and cash generation._ _Read the complete narrative._ Curious what sits behind that confidence in higher margins and cash generation. The narrative focuses on faster revenue growth and thicker profits than today. Investors may want to see exactly how those assumptions are expected to evolve over the next few years. **Result: Fair Value of £6.83 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, that upbeat story could be challenged if integrating Direct Line proves tougher than expected or if pressure on UK and Canadian personal lines pricing becomes more intense. Find out about the key risks to this Aviva narrative. ## Another view: earnings multiple sends a different signal While the SWS DCF model points to Aviva trading well below estimated future cash flow value at £12.46 versus the current £6.25, the P/E ratio tells a different story. At 24.8x, Aviva trades richer than the European insurance average of 12.6x and above its own fair ratio of 19.4x, which suggests less room for error if growth or margins fall short. Which signal do you weigh more heavily? See what the numbers say about this price — find out in our valuation breakdown. LSE:AV. P/E Ratio as at Mar 2026 ## Next Steps Mixed messages in the data so far. If this has you on the fence, check the numbers yourself and weigh 3 key rewards and 1 important warning sign before you decide what it really means. ## Looking for more investment ideas? If Aviva has sharpened your thinking, do not stop here, use the Simply Wall St screener to spot fresh ideas that fit your style before others do. - Target quality at a discount by scanning our list of 8 high quality undervalued stocks that pair fundamentals with appealing prices. - Prioritise resilience by checking companies in the 3 resilient stocks with low risk scores that score well on stability and risk metrics. - Hunt for future standouts using the screener containing 11 high quality undiscovered gems that many investors may not be watching yet. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [DLG.UK](https://longbridge.com/en/quote/DLG.UK.md) - [AVVIY.US](https://longbridge.com/en/quote/AVVIY.US.md) ## Related News & Research - [Aviva plc (LON:AV) Given Consensus Recommendation of "Hold" by Analysts](https://longbridge.com/en/news/285205855.md) - [AV Expands AV_Halo™ Platform with INSTINCT and DETECT to Enable Faster, Resilient Decision-Making at the Edge | AVAV Stock News](https://longbridge.com/en/news/286919252.md) - [Are Wall Street Analysts Predicting Brown & Brown Stock Will Climb or Sink?](https://longbridge.com/en/news/287220304.md) - [British Airways demands £10m from Heathrow over baggage fiasco](https://longbridge.com/en/news/286856876.md) - [Apyx Medical study shows 81.8% cellulite improvement using Avéli-Renuvion combo](https://longbridge.com/en/news/287215899.md)